Figures & data
Figure 1. The administration of glycerol injection in groups 1 and 2 induced rhabdomyolysis with severe increase of serum creatine-kinase (CK). The levels of CK in the group 2 were significantly lower than those of the group 1 (p<0.001). The CK in the groups 1 and 2 were significantly higher than those of the groups control (3 and 4) (p<0.0001).
![Figure 1. The administration of glycerol injection in groups 1 and 2 induced rhabdomyolysis with severe increase of serum creatine-kinase (CK). The levels of CK in the group 2 were significantly lower than those of the group 1 (p<0.001). The CK in the groups 1 and 2 were significantly higher than those of the groups control (3 and 4) (p<0.0001).](/cms/asset/211b4668-28ad-4384-a22c-643d5eb1ff2d/irnf_a_11379161_uf0001_b.gif)
Figure 2. Serum urea (top panel) and serum creatinine (bottom panel) values in four groups. In groups 1 and 2 the glycerol injection induced severe acute renal failure (ARF) serum urea in groups 1 and 2 were higher than in groups control: 3 and 4 (p<0.0001), and urea were higher in group 2 than in group 1 (p<0,001). Serum creatinine in groups 1 and 2 were higher than in groups control: 3 and 4 (p<0.0001), and creatinine were higher in group 2 than in group 1 (p<0.001).
![Figure 2. Serum urea (top panel) and serum creatinine (bottom panel) values in four groups. In groups 1 and 2 the glycerol injection induced severe acute renal failure (ARF) serum urea in groups 1 and 2 were higher than in groups control: 3 and 4 (p<0.0001), and urea were higher in group 2 than in group 1 (p<0,001). Serum creatinine in groups 1 and 2 were higher than in groups control: 3 and 4 (p<0.0001), and creatinine were higher in group 2 than in group 1 (p<0.001).](/cms/asset/5a335f7e-f4ed-439e-b0fb-3676fcc57e9e/irnf_a_11379161_uf0002_b.gif)
Figure 3. Total antioxidant status levels in group 1 was lower than in groups 2, 3, and 4 (p<0.005).
![Figure 3. Total antioxidant status levels in group 1 was lower than in groups 2, 3, and 4 (p<0.005).](/cms/asset/3005f264-d7d0-48e6-bf89-9d2c4dfe581e/irnf_a_11379161_uf0003_b.gif)
Table 1. General animal and laboratory data